Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Stela Capsule System

K-Number: K222583 · 2022-10-28

ApplicantSdi Limited
Decision Date2022-10-28
Product CodeEBF
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Stela Capsule System is a medical device manufactured by Sdi Limited. It received FDA 510(k) clearance on 2022-10-28 under approval number K222583. The device is classified under product code EBF. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Stela Capsule System?

Stela Capsule System is a medical device that received FDA 510(k) clearance on 2022-10-28. It is manufactured by Sdi Limited. The 510(k) number is K222583.

When was Stela Capsule System approved by the FDA?

Stela Capsule System received FDA 510(k) clearance on 2022-10-28, under approval number K222583.

What company makes Stela Capsule System?

Stela Capsule System is manufactured by Sdi Limited.

What is the FDA product code for Stela Capsule System?

The FDA product code for Stela Capsule System is EBF.

Related Clinical Trials

Other Devices by Sdi Limited

Related Devices (Code: EBF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.